Ophthalmic Immune-Related Adverse Events in Cancer Immunotherapy: Tissue-Specific Mechanisms, Clinical Phenotypes, and Consensus-Based Management.
- DOI
- 10.3390/ijms27135944
- Published
- 2026 Jul 1
- Container
- International journal of molecular sciences
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3390/ijms27135944,
title = {Ophthalmic Immune-Related Adverse Events in Cancer Immunotherapy: Tissue-Specific Mechanisms, Clinical Phenotypes, and Consensus-Based Management.},
author = {Zong Y and Yang M and Zhang J and Zou Y and Ye Z and Deng J and Gu W and Ohno-Matsui K and Kamoi K},
year = {2026},
journal = {International journal of molecular sciences},
doi = {10.3390/ijms27135944},
url = {https://doi.org/10.3390/ijms27135944}
}RIS
TY - JOUR TI - Ophthalmic Immune-Related Adverse Events in Cancer Immunotherapy: Tissue-Specific Mechanisms, Clinical Phenotypes, and Consensus-Based Management. AU - Zong Y AU - Yang M AU - Zhang J AU - Zou Y AU - Ye Z AU - Deng J AU - Gu W AU - Ohno-Matsui K AU - Kamoi K PY - 2026 JO - International journal of molecular sciences DO - 10.3390/ijms27135944 UR - https://doi.org/10.3390/ijms27135944 ER -
APA
Y, Z., M, Y., J, Z., Y, Z., Z, Y., J, D., W, G., K, O., & K, K. (2026). Ophthalmic Immune-Related Adverse Events in Cancer Immunotherapy: Tissue-Specific Mechanisms, Clinical Phenotypes, and Consensus-Based Management.. International journal of molecular sciences. https://doi.org/10.3390/ijms27135944
Source records
- pubmed · retrieved 2026-09-27T09:35:28.742Z